and second trimesters or because the concentration is above our plasma PCR detection limit in both trimesters.
On samples obtained from female-bearing pregnancies, no false-positive results were obtained with nested PCR on blood cell DNA, and only one false-positive result was obtained with nested PCR on plasma DNA. Conversely, with single PCR on plasma DNA, we obtained four false-positive results. We attributed the high-false positive rate of the single PCR to the higher number of cycles used to amplify fetal DNA compared with nested PCR, coupled with the double opening of the tube first for the addition of enzyme during the hot start, and then for the addition of enzyme and primers halfway through the PCR cycles, both of which are crucial for the efficiency of the reaction. Using single PCR on plasma DNA, we obtained two noninterpretable results because the samples produced smear (cases 21 and 26, Table 1 ).
The sensitivity (95% confidence intervals) of the three PCR methods was 100% (76 -99%) for nested PCR of plasma DNA; 94% (68 -99%) for single PCR on plasma DNA, similar to that reported (80%) (4 ); and 69% (42-88%) for nested PCR on blood cell DNA. The specificity (95% confidence intervals) of the three PCR methods was 100% (68 -99%) for nested PCR on blood cell DNA, 45% (18 -75%) for single PCR on plasma DNA, and 91% (57-99%) for nested PCR on plasma DNA. Nested PCR on plasma DNA had the highest number of correct identifications of fetal sex, although the difference was not statistically significant. We favor the use of nested PCR on plasma. A nested protocol does not imply any additional contamination risk and is no more time-consuming than a single 60-cycle hot-start PCR. The use of cellular material appears to offer no advantages in sensitivity over plasma. Plasma could thus be a naturally enriched, accessible, and useful material for the detection of fetal DNA sequences that does not require any extensive purification.
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Detection of a Deletion Polymorphism of the Human ␣ 2 -Macroglobulin Gene (A2M-2) by a Semi-Automated PCR-Single-Stranded Conformational Polymorphism
Method, Yan-Yun Wu, 1 Rosario M. Delgado, 1 Trey Sunderland, 2 and Gyorgy Csako 1* ( 1 Clinical Pathology Department, Warren G. Magnuson Clinical Center, and 2 Geriatric Psychiatry Branch, National Institute of Mental Health, NIH, Bethesda, MD 20892; * address correspondence to this author at: Clinical Pathology Department, NIH, Bldg. 10, Rm. 2C-407, Bethesda, MD 20892-1508; fax 301-402-1885, e-mail gcsako@nih.gov) Several genes such as the genes that code for apolipoprotein E4, amyloid ␤-precursor protein, and presenilin 1 and 2 have been linked to the development of Alzheimer disease (AD) (1 ) . Recently, a polymorphism of the human ␣ 2 -macroglobulin gene (A2M) was also identified as a risk factor for AD (2 ) . The A2M gene is located on chromosome 12p13.3-p12. 3 (3 ) , and its product (␣ 2 -macroglobulin) is a serum pan-proteinase inhibitor occurring in many organs and tissues (4 ) . Several studies have suggested that ␣ 2 -macroglobulin may have protective effect against the deposition of ␤-amyloids (5, 6 ) and may stimulate their degradation (7, 8 ) . A 5-nucleotide deletion mutation at the 5Ј splice site of "exon II" of the bait region (exon 18; A2M-2) may lead to loss of this protection because of its location at the functional domain, and this loss confers increased risk for AD (2 ) . Currently available methods based on DNA sequencing (2, 9 ) , heteroduplex formation in nondenaturing gel (9 ) , and PCR-restriction fragment length polymorphism (10 ) for detection of this deletion mutation are all relatively cumbersome for routine use in clinical laboratories. Here, we describe a semi-automated PCR-single-stranded conformational polymorphism (PCR-SSCP) detection method that is amenable to use for largescale screening.
Genomic DNA was extracted from EDTA-anticoagulated whole blood using the QIAamp blood kit (Qiagen). The A2M target DNA sequence was PCR amplified by modifying a previously described technique (9 ) . The 5Ј upstream primer was 5Ј-CTT TCC TTG ATG ACC CAA GCG CC-3Ј, and the 3Ј downstream primer was 5Ј-GTT GAA AAT AGT CAG CGA CCT C-3Ј. The PCR conditions were as follows: 37°C for 10 min; 95°C for 9 min; 30 cycles of 94°C for 1 min, 59°C for 40 s, and 72°C for 40 s. The PCR reaction mixture of 100 L contained 1 g of human genomic DNA, 20 pmol of each primer, 200 mol/L dNTPs, 2.5 mmol/L MgCl 2 , 50 mmol/L KCl, 10 mmol/L Tris-HCl (pH 8.3), 0.1 g/L gelatin, and 3 U of Gold AmpliTaq polymerase (Perkin-Elmer). In addition, 5 mol/L dUTP (Perkin-Elmer) and 10 kU/L uracil glycosylase (Perkin-Elmer) were added to the PCR mixtures to prevent contamination.
The PCR products were checked for purity by electrophoresis in 1% agarose gel followed by ethidium bromide staining. Images of the patterns were captured with a CCD camera (COHU) coupled with NIH image 1.62 software (NIH). The 326-bp PCR band was quantified by comparison to a DNA gel marker (Research Genetics).
SSCP analysis was performed essentially as described previously (11 ) . In short, the PCR products were mixed with an equal volume of denaturing/loading solution containing 980 mL/L formamide (Amresco), incubated at 95°C for 3 min, then immediately chilled on ice. Precast minigels with 20% homogeneous polyacrylamide and native buffer strips (Pharmacia Biotechnology) were used for electrophoresis. Gel electrophoresis and band development were carried out in the semi-automated PhastSystem TM (Pharmacia). The gels were prerun at 400 V, 10 mA, 1.0 W for 100 V⅐h at 4°C. Sample (1L) was applied at 25 V, 10 mA, 1.0 W for 2 V⅐h at 4°C, and then electrophoresed at 200 V, 5 mA, 1.0 W for 800 V⅐h at 4°C. The gels were silver stained according to the manufacturer's protocol.
To confirm the PCR-SSCP results, all PCR products were also analyzed by sequencing with the primer 5Ј-GTT GAA AAT AGT CAG CGA CCT C-3Ј, using an ABI Prism 310 genetic analyzer (PE Applied Biosystems) and Big Dye Terminator cycle sequencing kit (PE Applied Biosystems). Before sequencing, PCR products were purified either with a Gel Extraction kit (Qiagen) or a PCR Product Purification kit (Roche/Boehringer Mannheim).
Representative PCR-SSCP patterns for the three different A2M genotypes are shown in Fig. 1 . The same patterns were reproducible over a wide range of PCR products (2.5-30.0 ng), as quantified by the above-described image analysis method. When 30 human blood specimens were analyzed, a complete match was found between the PCR-SSCP and DNA sequencing results that included 16 cases of homozygous wild type (A2M/A2M), 11 cases of heterozygous type (A2M/A2M-2), and 3 cases of homozygous deletion type (A2M-2/A2M-2).
In summary, we have developed a semi-automated PCR-SSCP method that is simpler to perform and less labor-intensive than previous methods for the detection of A2M polymorphisms. In addition, PCR-SSCP avoids misinterpretation that may occur because of partial digestion in the PCR-restriction fragment length polymorphism method.
